J7330 HCPCS Level II code: Autologous cultured chondrocytes, implant

J7330 is the HCPCS code for “Autologous cultured chondrocytes, implant” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J7330

Autologous cultured chondrocytes, implant

Short description: Cultured chondrocytes implnt

HCPCS · United States

Medicare details

The indicators CMS publishes with J7330 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Other carrier priced
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Jan 1, 2001

Where J7330 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J7330Autologous cultured chondrocytes, implant

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J7330 mean?

J7330 is the HCPCS code for “Autologous cultured chondrocytes, implant” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J7330?

CMS lists J7330’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.